CNS - RadMD

The brains of RadMD will mind your trial

RadMD believes the foundation of any imaging trial is the expert radiologist to guide decision making and execution of image acquisition and reads that is critical to achieve the drug development goals. Neuro imaging in clinical trials is extensively used to assess qualitative, quantitative and safety endpoint that are key to determining the future of a compound and the patients we aim to treat.

Our neuroradiologist reader group has you covered

RadMD neuroradiologists are world leaders, published authors and clinical trialists who have read dozens of trials for patient eligibility, efficacy and safety including but not limited to:

Alzheimer’s Disease
Multiple Sclerosis
Stroke
Neuro-Oncology

Our founders, Kohkan Shamsi MD and Rick Patt MD were involved with development and approvals of Diagnostic Contrast Agents for CNS MRI and neuro PET agents for Alzheimer’s disease.

Imaging management solutions

Our full-service imaging management solutions provide a comprehensive set of services to support pharmaceutical, medical device, and AI companies with their clinical trials.

Our reader group

We are the global leader in providing consultants to perform imaging BICR (blinded independent central reviews)

Areas of expertise

With our deep reader pool and expert approach, RadMD is here to support you wherever your research leads

Oncology

A radiologist-led imaging provider focusing on blinded central and site reads with a specialty in oncology trials

Let’s work together

We’d love the chance to connect with you.